APA (7th ed.) Citation

Bamias, G., Menghini, P., Pizarro, T. T., & Cominelli, F. (2025). Targeting TL1A and DR3: The new frontier of anti-cytokine therapy in IBD. Gut, 74(4), 652-668. https://doi.org/10.1136/gutjnl-2024-332504

Chicago Style (17th ed.) Citation

Bamias, Giorgos, Paola Menghini, Theresa T. Pizarro, and Fabio Cominelli. "Targeting TL1A and DR3: The New Frontier of Anti-cytokine Therapy in IBD." Gut 74, no. 4 (2025): 652-668. https://doi.org/10.1136/gutjnl-2024-332504.

MLA (9th ed.) Citation

Bamias, Giorgos, et al. "Targeting TL1A and DR3: The New Frontier of Anti-cytokine Therapy in IBD." Gut, vol. 74, no. 4, 2025, pp. 652-668, https://doi.org/10.1136/gutjnl-2024-332504.